Literature DB >> 20692342

Reversal of age-related thymic involution by an LHRH agonist in miniature swine.

Atsushi Hirakata1, Masayoshi Okumi, Adam D Griesemer, Akira Shimizu, Shuji Nobori, Aseda Tena, Shannon Moran, Scott Arn, Richard L Boyd, David H Sachs, Kazuhiko Yamada.   

Abstract

UNLABELLED: BACKGROUND AND AIMS OF STUDY: We have previously demonstrated a requirement for the presence of a juvenile thymus for the induction of transplantation tolerance to renal allografts by a short-course of calcineurin inhibition in miniature swine. We have also shown that aged, involuted thymi can be rejuvenated when transplanted as vascularized thymic lobes into juvenile swine recipients. The present studies were aimed at elucidating the extrinsic factors facilitating this restoration of function in the aged thymus. In particular, we tested the impact of sex steroid blockade by Luteinizing Hormone-Releasing Hormone (LHRH).
MATERIALS AND METHODS: 30 naive animals (25 males and 5 females) were used for measurement of serum testosterone levels. 3 mature male pigs (aged at 22, 22 and 29 months old) were used to test the effects of Lupron (LHRH analog) injection at 45 mg (per 70-80 kg body weight) as a 3-month depot on testosterone levels and thymic rejuvenation. Thymic rejuvenation was assessed by histology, flow cytometric analysis, morphometric analysis and TREC assays.
RESULTS: Hormonal alterations were induced by Lupron and resulted in macroscopic and histologic regeneration of the thymus of aged animals within 2 months, as evidenced by restoration of juvenile thymus architecture and increased cellularity. Two animals that were evaluated for TREC both showed increased levels in the periphery following Lupron treatment.
CONCLUSION: Treatment of aged animals with Lupron leads to thymic rejuventaion in adult miniature swine. This result could expand the applicability of thymus-dependent tolerance-inducing regimens to adult recipients.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692342      PMCID: PMC2988885          DOI: 10.1016/j.trim.2010.08.001

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  41 in total

Review 1.  Interleukin-7: an interleukin for rejuvenating the immune system.

Authors:  Richard Aspinall; Sian Henson; Jeffrey Pido-Lopez; Pa Tamba Ngom
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

2.  Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group.

Authors:  R Sharifi; M Soloway
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

3.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Age-related decrease in mouse T cell progenitors.

Authors:  M L Tyan
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

Review 5.  Age and immune response in organ transplantation.

Authors:  Paulo N A Martins; Johann Pratschke; Andreas Pascher; Lutz Fritsche; Ulrich Frei; Peter Neuhaus; Stefan G Tullius
Journal:  Transplantation       Date:  2005-01-27       Impact factor: 4.939

6.  Serum thymulin in human zinc deficiency.

Authors:  A S Prasad; S Meftah; J Abdallah; J Kaplan; G J Brewer; J F Bach; M Dardenne
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Role of the thymus in transplantation tolerance in miniature Swine: IV. The thymus is required during the induction phase, but not the maintenance phase, of renal allograft tolerance.

Authors:  Parsia A Vagefi; Francesco L Ierino; Pierre R Gianello; Akira Shimizu; Chisako Kamano; David H Sachs; Kazuhiko Yamada
Journal:  Transplantation       Date:  2004-04-15       Impact factor: 4.939

8.  Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

Authors:  Sharon R Lewin; Glenn Heller; Linqi Zhang; Elaine Rodrigues; Eva Skulsky; Marcel R M van den Brink; Trudy N Small; Nancy A Kernan; Richard J O'Reilly; David D Ho; James W Young
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 9.  Reprogramming of the immune system during zinc deficiency.

Authors:  Pamela J Fraker; Louis E King
Journal:  Annu Rev Nutr       Date:  2004       Impact factor: 11.848

10.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more
  6 in total

1.  Immune aging and challenges for immune protection of the graying population.

Authors:  Abbe N Vallejo
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

2.  Role of Bone Marrow Maturity, Insulin-Like Growth Factor 1 Receptor, and Forkhead Box Protein N1 in Thymic Involution and Rejuvenation.

Authors:  M Tasaki; V Villani; A Shimizu; M Sekijima; R Yamada; I M Hanekamp; J S Hanekamp; T A Cormack; S G Moran; A Kawai; D H Sachs; K Yamada
Journal:  Am J Transplant       Date:  2016-06-13       Impact factor: 8.086

3.  The rejuvenating effects of leuprolide acetate on the aged baboon's thymus.

Authors:  Joseph R Scalea; Radbeh Torabi; Aseda Tena; Masayuki Tasaki; Bradford C Gillon; Shannon Moran; Taylor Cormack; Vincenzo Villani; Akira Shimizu; David H Sachs; Kazuhiko Yamada
Journal:  Transpl Immunol       Date:  2014-09-18       Impact factor: 1.708

Review 4.  A Tale from TGF-β Superfamily for Thymus Ontogeny and Function.

Authors:  Arnon Dias Jurberg; Larissa Vasconcelos-Fontes; Vinícius Cotta-de-Almeida
Journal:  Front Immunol       Date:  2015-09-10       Impact factor: 7.561

5.  Elevated levels of interferon-γ production by memory T cells do not promote transplant tolerance resistance in aged recipients.

Authors:  James I Kim; Ryan T Stott; Julie Soohoo; Kang Mi Lee; Gaoping Zhao; Heidi Yeh; Shaoping Deng; James F Markmann
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

6.  Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.

Authors:  Ryo Yamauchi; Yasuaki Takeyama; Kazuhide Takata; Atsushi Fukunaga; Kunitoshi Sakurai; Takashi Tanaka; Hiromi Fukuda; Sho Fukuda; Hideo Kunimoto; Kaoru Umeda; Daisuke Morihara; Keiji Yokoyama; Makoto Irie; Satoshi Shakado; Shotaro Sakisaka; Fumihito Hirai
Journal:  Intern Med       Date:  2020-01-17       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.